|
1
|
Reuben JM, Krishnamurthy S, Woodward W and
Cristofanilli M: The role of circulating tumor cells in breast
cancer diagnosis and prediction of therapy response. Expert Opin
Med Diagn. 2:339–348. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ngo H, Tortorella SM, Ververis K and
Karagiannis TC: The Warburg effect: Molecular aspects and
therapeutic possibilities. Mol Biol Rep. 42:825–834. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Halestrap AP: The monocarboxylate
transporter family-Structure and functional characterization. IUBMB
Life. 64:1–9. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kirk P, Wilson MC, Heddle C, Brown MH,
Barclay AN and Halestrap AP: CD147 is tightly associated with
lactate transporters MCT1 and MCT4 and facilitates their cell
surface expression. EMBO J. 19:3896–3904. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Wu Q and Sun S, Wu J, Li J, Zhang Y,
Wang C, Yuan J and Sun S: Monocarboxylate transporters in breast
cancer and adipose tissue are novel biomarkers and potential
therapeutic targets. Biochem Biophys Res Commun. 501:962–967. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pinheiro C, Reis RM, Ricardo S,
Longatto-Filho A, Schmitt F and Baltazar F: Expression of
monocarboxylate transporters 1, 2, and 4 in human tumours and their
association with CD147 and CD44. J Biomed Biotechnol.
2010:4276942010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeon JY, Lee M, Whang SH, Kim JW, Cho A
and Yun M: Regulation of acetate utilization by monocarboxylate
transporter 1 (MCT1) in hepatocellular carcinoma (HCC). Oncol Res.
26:71–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pinheiro C, Longatto-Filho A,
Azevedo-Silva J, Casal M, Schmitt FC and Baltazar F: Role of
monocarboxylate transporters in human cancers: State of the art. J
Bioenerg Biomembr. 44:127–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pinheiro C, Longatto-Filho A, Scapulatempo
C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA,
Schmitt F and Baltazar F: Increased expression of monocarboxylate
transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch.
452:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruan Y, Zeng F, Cheng Z, Zhao X, Fu P and
Chen H: High expression of monocarboxylate transporter 4 predicts
poor prognosis in patients with lung adenocarcinoma. Oncol Lett.
14:5727–5734. 2017.PubMed/NCBI
|
|
11
|
Kim Y, Choi JW, Lee JH and Kim YS:
Expression of lactate/H+ symporters MCT1 and MCT4 and
their chaperone CD147 predicts tumor progression in clear cell
renal cell carcinoma: Immunohistochemical and The Cancer Genome
Atlas data analyses. Hum Pathol. 46:104–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi JW, Kim Y, Lee JH and Kim YS:
Prognostic significance of lactate/proton symporters MCT1, MCT4,
and their chaperone CD147 expressions in urothelial carcinoma of
the bladder. Urology. 84:245.e9–245.e15. 2014. View Article : Google Scholar
|
|
13
|
Gerlinger M, Santos CR, Spencer-Dene B,
Martinez P, Endesfelder D, Burrell RA, Vetter M, Jiang M, Saunders
RE, Kelly G, et al: Genome-wide RNA interference analysis of renal
carcinoma survival regulators identifies MCT4 as a Warburg effect
metabolic target. J Pathol. 227:146–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marchiq I and Pouysségur J: Hypoxia,
cancer metabolism and the therapeutic benefit of targeting
lactate/H+ symporters. J Mol Med (Berl). 94:155–171.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Polański R, Hodgkinson CL, Fusi A, Nonaka
D, Priest L, Kelly P, Trapani F, Bishop PW, White A, Critchlow SE,
et al: Activity of the monocarboxylate transporter 1 inhibitor
AZD3965 in small cell lung cancer. Clin Cancer Res. 20:926–937.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guan X, Bryniarski MA and Morris ME: In
vitro and in vivo efficacy of the monocarboxylate transporter 1
inhibitor AR-C155858 in the murine 4T1 breast cancer tumor model.
AAPS J. 21:32018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Izumi H, Takahashi M, Uramoto H, Nakayama
Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S and Kohno K:
Monocarboxylate transporters 1 and 4 are involved in the invasion
activity of human lung cancer cells. Cancer Sci. 102:1007–1013.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JY, Lee I, Chang WJ, Ahn SM, Lim SH,
Kim HS, Yoo KH, Jung KS, Song HN, Cho JH, et al: MCT4 as a
potential therapeutic target for metastatic gastric cancer with
peritoneal carcinomatosis. Oncotarget. 7:43492–43503. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morais-Santos F, Granja S,
Miranda-Gonçalves V, Moreira AH, Queirós S, Vilaça JL, Schmitt FC,
Longatto-Filho A, Paredes J, Baltazar F, et al: Targeting lactate
transport suppresses in vivo breast tumour growth. Oncotarget.
6:19177–19189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang P, Ma J, Gao J, Liu F, Sun X, Fang
F, Zhao S and Liu H: Downregulation of monocarboxylate transporter
1 inhibits the invasion and migration through suppression of the
PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.
J Bioenerg Biomembr. 50:271–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong SC, Nøhr-Nielsen A, Zeeberg K,
Reshkin SJ, Hoffmann EK, Novak I and Pedersen SF: Monocarboxylate
transporters MCT1 and MCT4 regulate migration and invasion of
pancreatic ductal adenocarcinoma cells. Pancreas. 45:1036–1047.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rybakovsky E, Valenzano MC, DiGuilio KM,
Buleza NB, Moskalenko DV, Harty RN and Mullin JM: Improving
transient transfection efficiency in a differentiated, polar
epithelial cell layer. J Biomol Tech. 30:19–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rao DD, Vorhies JS, Senzer N and
Nemunaitis J: siRNA vs. shRNA: Similarities and differences. Adv
Drug Deliv Rev. 61:746–759. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romøren K, Thu BJ, Bols NC and Evensen Ø:
Transfection efficiency and cytotoxicity of cationic liposomes in
salmonid cell lines of hepatocyte and macrophage origin. Biochim
Biophys Acta. 1663:127–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Winer A, Adams S and Mignatti P: Matrix
metalloproteinase inhibitors in cancer therapy: Turning past
failures into future successes. Mol Cancer Ther. 17:1147–1155.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pachmayr E, Treese C and Stein U:
Underlying mechanisms for distant metastasis-molecular biology.
Visc Med. 33:11–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meirson T and Gil-Henn H: Targeting
invadopodia for blocking breast cancer metastasis. Drug Resist
Updat. 39:1–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sasaki S, Kobayashi M, Futagi Y, Ogura J,
Yamaguchi H, Takahashi N and Iseki K: Crucial residue involved in
L-lactate recognition by human monocarboxylate transporter 4
(hMCT4). PLoS One. 8:e676902013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsai PC, Hsieh CY, Chiu CC, Wang CK, Chang
LS and Lin SR: Cardiotoxin III suppresses MDA-MB-231 cell
metastasis through the inhibition of EGF/EGFR-mediated signaling
pathway. Toxicon. 60:734–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shojaei F, Simmons BH, Lee JH, Lappin PB
and Christensen JG: HGF/c-Met pathway is one of the mediators of
sunitinib-induced tumor cell type-dependent metastasis. Cancer
Lett. 320:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Navarini NF, Araújo VC, Brown AL,
Passador-Santos F, Souza IF, Napimoga MH, Araújo NS and Martinez
EF: The EGF signaling pathway influences cell migration and the
secretion of metalloproteinases by myoepithelial cells in
pleomorphic adenoma. Tumour Biol. 36:205–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levenson AS, Thurn KE, Simons LA,
Veliceasa D, Jarrett J, Osipo C, Jordan VC, Volpert OV, Satcher RL
Jr and Gartenhaus RB: MCT-1 oncogene contributes to increased in
vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and
inhibition of apoptosis. Cancer Res. 65:10651–10656. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Payen VL, Hsu MY, Rädecke KS, Wyart E,
Vazeille T, Bouzin C, Porporato PE and Sonveaux P: Monocarboxylate
transporter MCT1 promotes tumor metastasis independently of its
activity as a lactate transporter. Cancer Res. 77:5591–5601. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Majumder A, Ray S and Banerji A: Epidermal
growth factor receptor-mediated regulation of matrix
metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast
cancer cells. Mol Cell Biochem. 452:111–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
